BR112023022561A2 - Métodos e composições para o tratamento de retinopatia diabética e condições relacionadas - Google Patents
Métodos e composições para o tratamento de retinopatia diabética e condições relacionadasInfo
- Publication number
- BR112023022561A2 BR112023022561A2 BR112023022561A BR112023022561A BR112023022561A2 BR 112023022561 A2 BR112023022561 A2 BR 112023022561A2 BR 112023022561 A BR112023022561 A BR 112023022561A BR 112023022561 A BR112023022561 A BR 112023022561A BR 112023022561 A2 BR112023022561 A2 BR 112023022561A2
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- methods
- diabetic retinopathy
- related conditions
- treatment
- Prior art date
Links
- 206010012689 Diabetic retinopathy Diseases 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 206010012688 Diabetic retinal oedema Diseases 0.000 abstract 1
- 208000017442 Retinal disease Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 201000011190 diabetic macular edema Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163182037P | 2021-04-30 | 2021-04-30 | |
| PCT/US2022/027062 WO2022232597A1 (en) | 2021-04-30 | 2022-04-29 | Methods and compositions for treatment of diabetic retinopathy and related conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023022561A2 true BR112023022561A2 (pt) | 2024-01-02 |
Family
ID=83848745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023022561A BR112023022561A2 (pt) | 2021-04-30 | 2022-04-29 | Métodos e composições para o tratamento de retinopatia diabética e condições relacionadas |
Country Status (11)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025529483A (ja) | 2022-09-14 | 2025-09-04 | オーパス・ジェネティクス・インコーポレイテッド | Ａｐｘ３３３０の塩及びエステルならびにその治療的使用 |
| WO2024158972A1 (en) * | 2023-01-25 | 2024-08-02 | Ocuphire Pharma, Inc. | Methods and compositions for preventing the progression of diabetic retinopathy and related conditions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0817293A2 (pt) * | 2007-09-26 | 2015-06-16 | Univ Indiana Res & Tech Corp | Derivado de benzoquinona e3330 em combinação com agentes quimioterapêuticos para o tratamento de câncer e angiogenese |
| CA3090766A1 (en) * | 2018-02-08 | 2019-08-15 | Indiana University Research And Technology Corporation | Targeting ocular diseases with novel ape1/ref-1 inhibitors |
-
2022
- 2022-04-29 JP JP2023566803A patent/JP2024516003A/ja active Pending
- 2022-04-29 CA CA3217136A patent/CA3217136A1/en active Pending
- 2022-04-29 AU AU2022264037A patent/AU2022264037A1/en active Pending
- 2022-04-29 IL IL308083A patent/IL308083A/en unknown
- 2022-04-29 MX MX2023012793A patent/MX2023012793A/es unknown
- 2022-04-29 WO PCT/US2022/027062 patent/WO2022232597A1/en not_active Ceased
- 2022-04-29 US US18/288,435 patent/US20240216315A1/en active Pending
- 2022-04-29 EP EP22796862.5A patent/EP4329741A4/en active Pending
- 2022-04-29 BR BR112023022561A patent/BR112023022561A2/pt unknown
- 2022-04-29 KR KR1020237041163A patent/KR20240049212A/ko active Pending
- 2022-04-29 CN CN202280038694.0A patent/CN117500492A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022232597A1 (en) | 2022-11-03 |
| JP2024516003A (ja) | 2024-04-11 |
| MX2023012793A (es) | 2024-01-11 |
| US20240216315A1 (en) | 2024-07-04 |
| KR20240049212A (ko) | 2024-04-16 |
| EP4329741A1 (en) | 2024-03-06 |
| CA3217136A1 (en) | 2022-11-03 |
| IL308083A (en) | 2023-12-01 |
| EP4329741A4 (en) | 2025-01-08 |
| AU2022264037A1 (en) | 2023-11-16 |
| CN117500492A (zh) | 2024-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Harder et al. | Intravitreal bevacizumab for retinopathy of prematurity: refractive error results | |
| BR0013899A (pt) | Composto, composição farmacêutica, processos de tratamento ou prevenção de câncer, de uma doença em que a angiogênese esteja implicada, da vascularização retinal, da retinopatia diabética, da degeneração macular relacionada a idade, de doenças inflamatórias, de uma doença ou condições dependentes da tirosina quinase, de patologias associadas com ossos, e, processos para produzir uma composição farmacêutica, e de reduzir ou prevenir dano tecidual em seguida a um evento isquêmico cerebral | |
| BR112016015763B8 (pt) | preparação farmacêutica incluindo composto de ácido piridilaminocético, e, uso da mesma | |
| WO2021146536A8 (en) | Therapeutic agents and methods of treatment | |
| MX2023013338A (es) | Derivados de cannabidiol-c4 para el tratamiento de epilepsia. | |
| BR112021024744A2 (pt) | Método para melhorar, manter ou reduzir o comprometimento da capacidade funcional e função motora de um paciente humano com doença de huntington | |
| BR112022016761A2 (pt) | Compostos de derivado de 1,3,4-oxadiazol como inibidor de histona desacetilase 6 e a composição farmacêutica que compreende os mesmos | |
| JOP20230133A1 (ar) | استخدام منشطات sGC لمعالجة الأمراض العينية | |
| MX2023012793A (es) | Métodos y composiciones para el tratamiento de la retinopatía diabética y condiciones relacionadas. | |
| PH12020551015A1 (en) | Medicine for preventing or treating ophthalmic disease associated with enhanced intraocular neovascularization and/or intraocular vascular permeability | |
| CN114616230A (zh) | 黄烷类似物化合物及其在治疗慢性和急性疼痛中的用途 | |
| Sharma et al. | Single-stage adjustable strabismus surgery for restrictive strabismus | |
| MX2023004539A (es) | Compuestos y metodos para el tratamiento de trastornos oculares. | |
| BR112023018932A2 (pt) | Formulação para administração ocular, recipiente de dosagem, uso de uma formulação, e, método para o tratamento de um transtorno ocular | |
| BR112022025528A2 (pt) | Composto, composição farmacêutica, e, métodos para tratar atividade visual prejudicada, retinopatia diabética, edema macular diabético, oclusão de veia retinal, angioedema hereditário, diabete, pancreatite, hemorragia cerebral, nefropatia, cardiomiopatia, neuropatia, doença intestinal inflamatória, artrite, inflamação, choque séptico, hipotensão, câncer, síndrome da angústia respiratória do adulto, coagulação intravascular disseminada, coagulação sanguínea durante cirurgia de desvio cardiopulmonar ou hemorragia do pós-operatório de cirurgia e para tratar uveíte, uveíte posterior, edema macular relacionado com a idade úmido | |
| PH12020550722A1 (en) | Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye | |
| BR112022008095A2 (pt) | Métodos e composições para o tratamento da síndrome de rett | |
| MX2023004538A (es) | Compuestos y metodos para el tratamiento de trastornos oculares. | |
| RU2017111579A (ru) | Способы лечения и предотвращения заболеваний глаз, расстройств и патологических состояний меланином и аналогами, предшественниками и производными меланина | |
| BR112022017998A2 (pt) | Formulações de liberação controlada compreendendo drotaverina ou sal da mesma | |
| BR112021025409A2 (pt) | Composição livre de androgênio esteroidal | |
| RU95104837A (ru) | Способ хирургического лечения отслойки сетчатки, осложненной пролиферативной витреоретинопатией | |
| BR0307013A (pt) | Usos farmacêuticos | |
| Bakr et al. | Subtenon bupivacaine injection for postoperative pain relief following pediatric strabismus surgery: a randomized controlled double blind trial | |
| RU2469734C2 (ru) | Лечебное средство для лечения расстройств аккомодаций "stiak" |